BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 24, 2009
View Archived Issues
Bristol-Myers Squibb claims DGAT-1 inhibitors for the treatment of obesity
Read More
Takeda describes novel AR antagonists for cancer therapy
Read More
Yakult Honsha discloses novel MMP inhibitors for cancer therapy
Read More
Novel GK activators for the treatment of diabetes presented by Roche
Read More
Intra-Cellular Therapies reports results of a phase I PET study for ITI-007
Read More
European CHMP recommends approval of Novartis's MAA for Menveo vaccine
Read More
Insulin secretion stimulators in development Merck KGaA for type 2 diabetes therapy
Read More
Athersys enters into global agreement with Pfizer to develop MultiStem for IBD
Read More
CombinatoRx and Neuromed close merger
Read More
CPEX completes enrollment in phase IIa Nasulin trial
Read More
Michael J. Fox Foundation awards grant for dyskinesia treatment development
Read More
Soligenix initiates phase I/II SGX-201 trial for acute radiation enteritis
Read More
FDA grants TessArae Emergency Use Authorization for TessArray assay
Read More
PDL and Lilly sign license agreement for teplizumab and other anti-CD3 molecules
Read More
TG-101348 reduces JAK2 V617F allele burden in phase I myelofibrosis trial
Read More
BHQ-880 shown to be safe in combination with zoledronic acid and MM therapy
Read More
GP2/GM-CSF peptide vaccine may prevent breast cancer recurrence
Read More
Fluticasone furoate nasal spray may be beneficial in children with otitis media
Read More
Vadimezan added to taxane-containing regimens evaluated in mouse breast cancer models
Read More
Clinuvel reports results from phase III trial of afamelanotide in erythropoietic protoporphyria
Read More
Neurocrine to initiate clinical development of VMAT2 inhibitor NBI-98854
Read More
4SC initiates three clinical trials in oncology pipeline
Read More
Idera reports interim results from phase I clinical trial of IMO-2125 in chronic HCV
Read More
Leo Pharma reports results from phase III clinical trials of PEP-005
Read More
NicOx submits MAA to EMEA for anti-inflammatory drug naproxcinod
Read More